Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 20 citing articles:

Oxidative Stress: A Culprit in the Progression of Diabetic Kidney Disease
Na Wang, Chun Zhang
Antioxidants (2024) Vol. 13, Iss. 4, pp. 455-455
Open Access | Times Cited: 39
Recent Advances in the Management of Diabetic Kidney Disease: Slowing Progression
Na Wang, Chun Zhang
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 6, pp. 3086-3086
Open Access | Times Cited: 22
What’s New in the Molecular Mechanisms of Diabetic Kidney Disease: Recent Advances
Kimio Watanabe, Emiko Sato, Eikan Mishima, et al.
International Journal of Molecular Sciences (2022) Vol. 24, Iss. 1, pp. 570-570
Open Access | Times Cited: 48
Tubular injury in diabetic kidney disease: molecular mechanisms and potential therapeutic perspectives
Yu Wang, Mingyue Jin, Chak Kwong Cheng, et al.
Frontiers in Endocrinology (2023) Vol. 14
Open Access | Times Cited: 33
Placental Mesenchymal Stem Cells Alleviate Podocyte Injury in Diabetic Kidney Disease by Modulating Mitophagy via the SIRT1-PGC-1alpha-TFAM Pathway
Xiudan Han, Jiao Wang, Ruilin Li, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 5, pp. 4696-4696
Open Access | Times Cited: 29
Placenta-derived mesenchymal stem cells protect against diabetic kidney disease by upregulating autophagy-mediated SIRT1/FOXO1 pathway
Honghong Liu, Jiao Wang, Guanru Yue, et al.
Renal Failure (2024) Vol. 46, Iss. 1
Open Access | Times Cited: 9
Therapeutic potential: The role of mesenchymal stem cells from diverse sources and their derived exosomes in diabetic nephropathy
Lixin Liu, Yiman Chen, Xuan Li, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 175, pp. 116672-116672
Open Access | Times Cited: 9
Protective effect of compound K against podocyte injury in chronic kidney disease by maintaining mitochondrial homeostasis
Fugang Huang, Shuo Huang, Ke Sun, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access | Times Cited: 1
Body fluid-derived stem cells — an untapped stem cell source in genitourinary regeneration
Ru‐Lin Huang, Qingfeng Li, Jian‐xing Ma, et al.
Nature Reviews Urology (2023) Vol. 20, Iss. 12, pp. 739-761
Closed Access | Times Cited: 14
Repeated administration of adipose-derived mesenchymal stem cells added on beneficial effects of empagliflozin on protecting renal function in diabetic kidney disease rat
Chih‐Chao Yang, Yi-Ling Chen, Pei‐Hsun Sung, et al.
Biomedical Journal (2023) Vol. 47, Iss. 2, pp. 100613-100613
Open Access | Times Cited: 12
New perspectives on the treatment of diabetic nephropathy: Challenges and prospects of mesenchymal stem cell therapy
Canyu Chen, Bo Xu, Weiyi Li, et al.
European Journal of Pharmacology (2025), pp. 177543-177543
Closed Access
The Role of Dental-derived Stem Cell-based Therapy and Their Derived Extracellular Vesicles in Post-COVID-19 Syndrome-induced Tissue Damage
Mitra Rostami, Pouria Farahani, Samar Esmaelian, et al.
Stem Cell Reviews and Reports (2024) Vol. 20, Iss. 8, pp. 2062-2103
Closed Access | Times Cited: 2
Synergic Effect of Early Administration of Probiotics and Adipose-Derived Mesenchymal Stem Cells on Alleviating Inflammation-Induced Chronic Neuropathic Pain in Rodents
Kuan‐Hung Chen, Hung-Sheng Lin, Yi‐Chen Li, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 19, pp. 11974-11974
Open Access | Times Cited: 11
Recent Advances on Therapy of Slowing Progression of Dia-betic Kidney Disease
Na Wang, Chun Zhang
(2024)
Open Access | Times Cited: 1
Oxidized-LDL Deteriorated the Renal Residual Function and Parenchyma in CKD Rat through Upregulating Epithelial Mesenchymal Transition and Extracellular Matrix-Mediated Tubulointerstitial Fibrosis—Pharmacomodulation of Rosuvastatin
Pei‐Hsun Sung, Ben‐Chung Cheng, Tsuen‐Wei Hsu, et al.
Antioxidants (2022) Vol. 11, Iss. 12, pp. 2465-2465
Open Access | Times Cited: 5
Mesenchymal Stem Cell Therapy: Therapeutic Opportunities and Challenges for Diabetic Kidney Disease
Jia Cheng, Chun Zhang
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 19, pp. 10540-10540
Open Access
Hydrogel Biomaterial in Bone Tissue Engineering
Emıne Alarçın, Gökçen Yaşayan, Ayça Bal‐Öztürk, et al.
(2024), pp. 387-427
Closed Access
Research advance in mesenchymal stem cell-based therapy for diabetic nephropathy
Hui Yan, Yuyang Dong, Y. Liu
Archives of Physiology and Biochemistry (2024), pp. 1-14
Closed Access
Addition of adipose tissue-derived mesenchymal stem cells improves empagliflozin therapy for alleviating hyperglycemia--induced neuropathy.
Hung-Sheng Lin, Chien‐Hui Yang, Tsung‐Cheng Yin, et al.
PubMed (2023) Vol. 15, Iss. 10, pp. 6264-6285
Closed Access | Times Cited: 1
Utilization of Hydrogels in Mesenchymal Stem Cell-Based Therapy for Kidney Diseases
Jing Peng, Tinghang Yang, Shanshan Chen, et al.
Tissue Engineering Part B Reviews (2023) Vol. 30, Iss. 3, pp. 315-326
Closed Access
Page 1

Scroll to top